References
Adams J. 1986. Methods in behavioral teratology. In: Handbook of Behavioral Teratology (Riley EP, Vorhees CV, eds). New York:Plenum Press, 67–97.
Adams J, Buelke-Sam J, Kimmel CA, Nelson CJ, Miller DR. 1985a. Collaborative Behavioral Teratology Study: preliminary research. Neurobehav Toxicol Teratol 7:555–578.
Adams J, Buelke-Sam J, Kimmel CA, Nelson CJ, Reiter LW, Sobotka TJ, et al. 1985b. Collaborative Behavioral Teratology Study: protocol design and testing procedures. Neurobehav Toxicol Teratol 7:579–586.
Adams J, Oglesby DM, Ozemek HS, Rath J, Kimmel CA, Buelke-Sam J. 1985c. Collaborative Behavioral Teratology Study: programmed data entry and automated test systems. Neurobehav Toxicol Teratol 7:547–554.
Adams J, Vorhees CV, Middaugh LD. 1990. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol Teratol 12:203–214.
Alder S, Candrian R, Elsner J, Zbinden G. 1986. Neurobehavioral screening in rats: validation study. Methods Find Exp Clin Pharmacol 8:279–289.
Andersen HR, Nielsen JB, Grandjean P. 2000. Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology 144:121–127.
Balls M, Combes R. 2005. The need for a formal invalidation process for animal and non-animal tests. Altern Lab Anim 33:299–308.
Barlow SM, Sullivan FM. 1975. Behavioral teratology. In: Teratology: Trends and Applications (Berry CL, Poswillo DE, eds). New York:Springer-Verlag, 103–120.
Brent R, Weitzman M, Balk S, Lanphear B, Landrigan P, Reigart R, eds. 2004. The vulnerability, sensitivity, and resiliency of the developing embryo, infant, child, and adolescent to the effects of environmental chemicals, drugs, and physical agents as compared to the adult. Pediatrics 113(suppl):933–1172.
Buelke-Sam J, Kimmel CA, Adams J, Nelson CJ, Vorhees CV, Wright DC, et al. 1985. Collaborative Behavioral Teratology Study: results. Neurobehav Toxicol Teratol 7:591–624.
Buelke-Sam J, Mactutus CF. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group II report: testing methods in developmental neurotoxicity for use in human risk assessment. Neurotoxicol Teratol 12:269–274.
Burbacher TM, Rodier PM, Weiss B. 1990. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol 12:191–202.
Butcher RE, Hoar RM, Nolan GA, Vorhees CV. 1979. Interlaboratory comparison of behavioral testing. J Assoc Off Anal Chem 62:840–843.
Butcher RE, Nelson CJ. 1985. Design and analysis issues in behavioral teratology testing. Neurobehav Toxicol Teratol 7:659.
Butcher RE, Vorhees CV. 1979. A preliminary test battery for the investigation of the behavioral teratology of selected psychotropic drugs. Neurobehav Toxicol 1:207–212.
Catalano PJ, McDaniel KL, Moser VC. 1997. The IPCS Collaborative Study on Neurobehavioral Screening Methods: VI. Agreement and reliability of the data. Neurotoxicology 18:1057–1064.
Chemical Manufacturers Association. 1987. Comments on proposed test rule for glycol ethers by the Chemical Manufacturers Association. Fed Reg 53(38):5935–5936.
Chiarotti F, Puopolo M. 2000. Refinement in behavioral research: a statistical approach. In: Progress in Reduction, Refinement and Replacement of Animal Experimentation (Balls M, van Zeller AM, Halder ME, eds). Oxford:Elsevier, 1229–1237.
Claudio L, Bearer CF, Wallinga D. 1999. Assessment of the U.S. Environmental Protection Agency methods for identification of hazards to developing organisms, part II: the developmental toxicity testing guideline. Am J Ind Med 35:554–563.
Claudio L, Kwa WC, Russell AL, Wallinga D. 2000. Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol Appl Pharmacol 164:1–14.
Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, et al. 2007. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 115:924–931.
Combes R, Barratt M, Balls M. 2003. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system. Altern Lab Anim 31:7–19.
Cooper RL, Lamb JC, Barlow SM, Bentley K, Brady AM, Doerrer NG, et al. 2006. A tiered approach to life stages testing for agricultural chemical safety assessment. Crit Rev Toxicol 36:69–98.
Cory-Slechta DA, Crofton KM, Foran JA, Ross JF, Sheets LP, Weiss B, et al. 2001. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects. Environ Health Perspect 109(suppl 1):79–91.
Crofton KM, Foss JA, Hass U, Jensen K, Levin ED, Parker SL. 2008. Undertaking positive control studies as part of developmental neurotoxicity testing. Neurotoxicol Teratol 30(4):266–287.
Crofton KM, Howard JL, Moser VC, Gill MW, Reiter LW, Tilson HA, et al. 1991. Interlaboratory comparison of motor activity experiments: implications for neurotoxicological assessments. Neurotoxicol Teratol 13:599–609.
Crofton KM, Makris SL, Sette WF, Mendez E, Raffaele KC. 2004. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicol Teratol 26:345–352.
Crofton KM, Sutton JL, Makris SL, Raffaele K, Sette WF. 2001. Developmental neurotoxicity testing guidelines: variability in morphometric assessments of neuropathology. Toxicologist 60:113.
Davis JM, Otto DA, Weil DE, Grant LD. 1990. The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol Teratol 12:215–229.
Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95:5–12.
Dorman DC, Allen SL, Byczkowski JZ, Claudio L, Fisher JE Jr, Fisher JW, et al. 2001. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III. Pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect 109(suppl 1):101–111.
Driscoll CD, Streissguth AP, Riley EP. 1990. Prenatal alcohol exposure: comparability of effects in humans and animal models. Neurotoxicol Teratol 12:231–237.
Elsner J. 1986. Testing strategies in behavioral teratology: III. Microanalysis of behavior. Neurobehav Toxicol Teratol 8:573–584.
Elsner J, Hodel B, Suter KE, Oelke D, Ulbrich B, Schreiner G, et al. 1988. Detection limits of different approaches in behavioral teratology, and correlation of effects with neurochemical parameters. Neurotoxicol Teratol 10:155–167.
Elsner J, Suter KE, Ulbrich B, Schreiner G. 1986. Testing strategies in behavioral teratology: IV. Review and general conclusions. Neurobehav Toxicol Teratol 8:585–590.
European Commission. 2006. Registration Evaluation, Authorization and Restriction of Chemicals (REACH). Regulation (EC) No. 1907/2006 of the European Parliament and of the Council. Off J Eur Union. Available: http://tsar.jrc.ec.europa.eu/documents/TSAR_REACH_corrected_
2007_05_29.pdf [accessed 21 November 2008].
Fenner-Crisp PA, Adams J, Balbus J, Bellinger D, Brimijoin S, Makris SL, et al. 2005. Application of developmental neurotoxicity testing to public health protection. Neurotoxicol Teratol 27:371.
Food Quality Protection Act of 1996. Public Law 104-170.
Francis EZ, Kimmel CA, Rees DC. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications. Neurotoxicol Teratol 12:285–292.
Fukunishi K, Terada Y, Tachibana T, Tanimura T. 1998. Collaborative behavioral teratology study of phenytoin: a test battery for neurobehavioral developmental toxicity in rats. Congenit Anom 38:117–141.
Gad SC. 1982. A neuromuscular screen for use in industrial toxicology. J Toxicol Environ Health 9:691–704.
Garman RH, Fix AS, Jortner BS, Jensen KF, Hardisty JF, Claudio L, et al. 2001. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology. Environ Health Perspect 109(suppl 1):93–100.
Gerber GJ, O’Shaughnessy D. 1986. Comparison of the behavioral effects of neurotoxic and systemically toxic agents: how discriminatory are behavioral tests of neurotoxicity? Neurobehav Toxicol Teratol 8:703–710.
Geyer MA, Reiter LW. 1985. Strategies for the selection of test methods. Neurobehav Toxicol Teratol 7:661–662.
Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity of industrial chemicals. Lancet 368:2167–2178.
Holson RR, Freshwater L, Maurissen JP, Moser V, Phang W. 2008. Statistical issues and techniques appropriate for developmental neurotoxicity testing. Neurotoxicol Teratol 30(4):326–348.
Hutchings DE. 1990. Issues of risk assessment: lessons from the use and abuse of drugs during pregnancy. Neurotoxicol Teratol 12:183–189.
IPCS. 2001. Environmental Health Criteria 223: Neurotoxicity Risk Assessment for Human Health: Principles and Approaches. Geneva:International Programme on Chemical Safety, World Health Organization.
Irwin S. 1968. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222–257.
Kaufmann W, Groters S. 2006. Developmental neuropathology in DNT-studies—a sensitive tool for the detection and characterization of developmental neurotoxicants. Reprod Toxicol 22:196–213.
Kavlock RJ, Ankley G, Blancato J, Breen M, Conolly R, Dix D, et al. 2008. Computational toxicology—a state of the science mini review. Toxicol Sci doi:10.1093/toxsci/kfm297 [Online 7 December 2007].
Kimmel CA, Buelke-Sam J. 1985. Collaborative Behavioral Teratology Study: background and overview. Neurobehav Toxicol Teratol 7:541–545.
Kimmel CA, Buelke-Sam J, Adams J. 1985. Collaborative Behavioral Teratology Study: implications, current applications and future directions. Neurobehav Toxicol Teratol 7:669–673.
Kimmel CA, Rees DC, Francis EZ, eds. 1990. Qualitative and quantitative comparability of human and animal developmental neurotoxicity. Neurotoxicol Teratol 12:173–292.
Kutscher CL, Nelson BK. 1985. Dosing considerations in behavioral teratology testing. Neurobehav Toxicol Teratol 7:663–664.
Ladics GS, Chapin RE, Hastings KL, Holsapple MP, Makris SL, Sheets LP, et al. 2005. Developmental toxicology evaluations—issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol Sci 88:24–29.
Lein P, Locke P, Goldberg A. 2007. Meeting report: alternatives for developmental neurotoxicity testing. Environ Health Perspect 115:764–768.
Levine TE, Butcher RE. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: triggers for developmental neurotoxicity testing. Neurotoxicol Teratol 12:281–284.
Li A. 2005. Regulatory developmental neurotoxicology testing: data evaluation for risk assessment purposes. Environ Toxicol Pharmacol 19:727–733.
MacPhail RC, Peele DB, Crofton KM. 1989. Motor activity and screening for neurotoxicity. J Am Coll Toxicol 8:117–125.
MacPhail RC, Tilson HA, Moser VC, Becking GC, Cuomo V, Frantik E, et al. 1997. The IPCS Collaborative Study on Neurobehavioral Screening. I. Background and genesis. Neurotoxicology 18:925–928.
Makris S, Raffaelle K, Sette W, Seed J. 1998. A Retrospective Analysis of Twelve Developmental Neurotoxicity Studies. Available: http://www.epa.gov/scipoly/sap/meetings/1998/120898_mtg.htm#materials [accessed 21 November 2008].
Makris SL, Crofton KM, Doherty J, Raffaele KC, Mendez E, Schumacher K. 2006. Retrospective review of developmental neurotoxicity studies utilizing gavage dosing of pre-weaning rats demonstrates no adverse consequences of dosing procedures on brain morphometry. Toxicologist 90:291.
Makris SL, Mendez E, Raffaele KC. 2005. A retrospective review of studies utilizing gavage dosing of pre-weaning rats demonstrated no adverse consequences of dosing procedures. Toxicologist 84:77.
Middaugh LD, Dow-Edwards D, Li AA, Sandler JD, Seed J, Sheets LP, et al. 2003. Neurobehavioral assessment: a survey of use and value in safety assessment studies. Toxicol Sci 76:250–261.
Mileson BE, Ferenc SA. 2001. Methods to identify and characterize developmental neurotoxicity for human health risk assessment: overview. Environ Health Perspect 109(suppl 1):77–78.
Mizutani M. 1984. Joint studies by 31 laboratories on some experimental conditions of water multiple-T-maze and active avoidance test. Congenit Anom 24:265.
Mizutani M. 1985. Collaborative studies on behavioral teratology by 46 laboratories: effects of behavioral teratogenic chemicals on the learning behavior of the rat. Congenit Anom 25:197.
Moser VC, Becking GC, Cuomo V, Frantik E, Kulig BM, MacPhail RC, et al. 1997a. The IPCS Collaborative Study on Neurobehavioral Screening Methods: III. Results of proficiency studies. Steering Group. Neurotoxicology 18:939–946.
Moser VC, Becking GC, Cuomo V, Frantik E, Kulig BM, MacPhail RC, et al. 1997b. The IPCS Collaborative Study on Neurobehavioral Screening Methods: IV. Control data. Steering Group. Neurotoxicology 18:947–967.
Moser VC, Becking GC, Cuomo V, Frantik E, Kulig BM, MacPhail RC, et al. 1997c. The IPCS Collaborative Study on Neurobehavioral Screening Methods: V. Results of chemical testing. Steering Group. Neurotoxicology 18:969–1055.
Moser VC, Becking GC, MacPhail RC, Kulig BM. 1997d. The IPCS collaborative study on neurobehavioral screening methods. Fundam Appl Toxicol 35:143–151.
Moser VC, McCormick JP, Creason JP, MacPhail RC. 1988. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam Appl Toxicol 11:189–206.
Moser VC, Tilson HA, MacPhail RC, Becking GC, Cuomo V, Frantik E, et al. 1997e. The IPCS Collaborative Study on Neurobehavioral Screening Methods: II. Protocol design and testing procedures. Neurotoxicology 18:929–938.
Moser VC, Walls I, Zoetis T. 2005. Direct dosing of pre-weaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group. Int J Toxicol 24:87–94.
Nelson BK. 1986. Developmental neurotoxicology of in utero exposure to industrial solvents in experimental animals. Neurotoxicology 7:441–447.
Nelson CJ, Felton RP, Kimmel CA, Buelke-Sam J, Adams J. 1985. Collaborative Behavioral Teratology Study: statistical approach. Neurobehav Toxicol Teratol 7:587–590.
Nishmura T, Iwase T, Hasimoto Y, Tanimura T. 2001. Evaluation of a core battery of tests for detecting behavioral dysfunction of rat offspring induced by retinoic acid: collaborative work II of the Japanese Behavioral Teratology Committee. Congenit Anom 41:156–168.
Nolen GA. 1985. An industrial developmental toxicologist’s view of behavioral teratology and possible guidelines. Neurobehav Toxicol Teratol 7:653–657.
NRC (National Research Council). 1984. Toxicity Testing: Strategies to Determine Needs and Priorities. Washington, DC:National Academy Press.
NRC (National Research Council). 1992. Environmental Neurotoxicology. Washington, DC:National Academy Press.
NRC (National Research Council). 1993. Pesticides in the Diets of Infants and Children. Washington, DC:National Academy Press.
NRC (National Research Council). 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC:National Academy Press.
NRC (National Research Council). 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC:National Academies Press.
OECD. 1983. Test Guideline 415. OECD Guideline for Testing of Chemicals. One-Generation Reproduction Toxicity Study. Paris:Organisation for Economic Co-operation and Development. Available: http://www.oecd.org/document/40/0,3343,en_2649_34377_37051368_1_1_1_1,00.html [accessed 6 August 2008].
OECD. 1995. Draft Report of the OECD Ad Hoc Working Group on Reproduction and Developmental Toxicity. Paris:Organisation for Economic Co-operation and Development.
OECD. 1996a. Final Report of the OECD Consultation Meeting on Developmental Neurotoxicity. Paris:Organisation for Economic Co-operation and Development.
OECD. 1996b. Report of the OECD Workshop on “Harmonisation of Validation and Acceptance Criteria for Alternative Toxicological Test Methods” (Solna Report). ENV/MC/CHEM(96)9. Paris:Organisation of Economic Co-operation and Development.
OECD. 1997. Test Guideline 424. OECD Guideline for Testing of Chemicals. Neurotoxicity Study in Rodents. Paris:Organisation for Economic Co-operation and Development. Available: http://www.oecd.org/document/40/0,3343,en_2649_34377_37051368_1_1_1_1,00.html [accessed 6 August 2008].
OECD. 2001. Test Guideline 414. OECD Guideline for Testing of Chemicals. Prenatal Developmental Toxicity Study. Paris:Organisation for Economic Co-operation and Development. Available: http://www.oecd.org/document/40/0,3343,en_2649_34377_37051368_1_1_1_1,00.html [accessed 6 August 2008].
OECD. 2003. Report of the OECD Expert Consultation Meeting on Developmental Neurotoxicity Testing, Washington, DC, 23–25 October 2000. Paris:Organisation for Economic Co-operation and Development.
OECD. 2005a. OECD Series on Testing and Assessment, Number 34: Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment. ENV/JM/MONO(2005)14. Paris:Organisation for Economic Co-operation and Development.
OECD. 2005b. Report of the Expert Consultation Meeting for the Revision of Draft Test Guideline 426 on Developmental Neurotoxicity. Paris:Organisation for Economic Co-operation and Development.
OECD. 2007. Test Guideline 426. OECD Guideline for Testing of Chemicals. Developmental Neurotoxicity Study. Paris:Organisation for Economic Co-operation and Development. Available: http://lysander.sourceoecd.org/vl=861182/cl=34/nw=1/rpsv/ij/oecdjournals/1607310x/v1n4/s27/p1 [accessed 9 December 2008].
OECD. 2008a. OECD Series on Testing and Assessment, Number 89: Retrospective Performance Assessment of the Test Guideline 426 on Developmental Neurotoxicity. ENV/JM/MONO(2008)15. Paris:Organisation for Economic Co-operation and Development. Available: http://www.olis.oecd.org/olis/2008doc.nsf/LinkTo/NT000035EA/$FILE/JT03249260.PDF [accessed 8 December 2008].
OECD. 2008b. OECD Series on Testing and Assessment, Number 43: Guidance Document on Mammalian Reproductive Toxicity Testing and Assessment. ENV/JM/MONO(2008)16. Paris:Organisation for Economic Co-operation and Development. Available: http://www.olis.oecd.org/olis/2008doc.nsf/LinkTo/NT0000358A/$FILE/JT03249193.PDF [accessed 8 December 2008].
Office of Technology Assessment. 1990. Neurotoxicity: Identifying and Controlling Poisons of the Nervous System. OTA-BA-438. Washington, DC:Office of Technology Assessment.
Okazaki S, Takashima H, Yamaguchi M, Hamamura M, Yamashita K, Okada M, et al. 2003. Neurobehavioral toxicity of acrylamide and IDPN (3,3´-iminodipropionitrile) in rats by 28-day oral administration—problems encountered in collaborative study and a commentary on conducting neurobehavioral testing. J Toxicol Sci 28(suppl 1):1–14.
Pryor GT, Uyeno ET, Tilson HA, Mitchell CL. 1983. Assessment of chemicals using a battery of neurobehavioral tests: a comparative study. Neurobehav Toxicol Teratol 5:91–117.
Puopolo M. 2004. Biostatistical approaches to reducing the number of animals used in biomedical research [in Italian]. Ann Ist Super Sanita 40:157–163.
Raffaele KC, Fisher JE, Hancock S, Hazelden KP, Sobrian SK. 2008. Determining normal variability in a developmental neurotoxicity test. Neurotoxicol Teratol 30(4):288–325.
Raffaele KC, Gilbert ME, Crofton S. 2004. Learning and memory tests in developmental neurotoxicity testing: a cross-
laboratory comparison of control data. Toxicologist 78:276.
Raffaele KC, Gilbert ME, Crofton KM, Mendez E, Doherty JD, Schumacher W, et al. 2006. Evaluation of learning and memory in developmental neurotoxicity studies: comparison of single-choice water maze across laboratories. Toxicologist 90:291.
Raffaele KC, Sette W, Doherty JD, Makris SL, Crofton KM. 2005. Neuropathological findings in developmental neurotoxicity testing: comparison of qualitative and quantitative evaluations. Toxicologist 84:200.
Raffaele KC, Sette W, Makris SL, Moser V, Crofton KM. 2003. Motor activity in developmental neurotoxicity testing: a cross-laboratory comparison of control data. Toxicologist 72:123.
Rice D, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(suppl 3):511–533.
Rodier PM. 1980. Chronology of neuron development: animal studies and their clinical implications. Dev Med Child Neurol 22:525–545.
Rodier PM. 1986. Time of exposure and time of testing in developmental neurotoxicology. Neurotoxicology 7:69–76.
Rodier PM. 1994. Vulnerable periods and processes during central nervous system development. Environ Health Perspect 102(suppl 2):121–124.
Rowland J, Makris SL, Raffaele K, Schumacher K, Scarano L. 2007. A retrospective review of the use of the developmental neurotoxicity study in pesticide risk assessments. Toxicologist 96:369.
Schreiner G, Ulbrich B, Bass R. 1986. Testing strategies in behavioral teratology: II. Discrimination learning. Neurobehav Toxicol Teratol 8:567–572.
Schull WJ, Norton S, Jensh RP. 1990. Ionizing radiation and the developing brain. Neurotoxicol Teratol 12:249–260.
Sette WF, Crofton KM, Makris SL, Doherty JD, Raffaele KC. 2004. Auditory startle reflex habituation in developmental neurotoxicity testing: a cross-laboratory comparison of control data. Toxicologist 78:275.
Slikker W Jr, Acuff K, Boyes WK, Chelonis J, Crofton KM, Dearlove GE, et al. 2005. Behavioral test methods workshop. Neurotoxicol Teratol 27:417–427.
Sobotka TJ, Vorhees CV. 1985. Application of behavioral teratology testing procedures. Neurobehav Toxicol Teratol 7:665.
Spencer PJ, Mattsson JL, Johnson KA, Albee RR. 1993. Neurotoxicity screening methods are sensitive to experimental history. Int J Psychophysiol 14:5–19.
Spyker JM, Smithberg M. 1972. Effects of methylmercury on prenatal development in mice. Teratology 5:181–190.
Stanton ME, Spear LP. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol 12:261–267.
Stein J, Schettler T, Wallinga D, Valenti M. 2002. In harm’s way: toxic threats to child development. J Dev Behav Pediatr 23:S13–S22.
Suter KE, Schon H. 1986. Testing strategies in behavioral teratology: I. Testing battery approach. Neurobehav Toxicol Teratol 8:561–566.
Tachibana T, Narita H, Ogawa T, Tanimura T. 1998. Using postnatal age to determine test dates leads to misinterpretations when treatments alter gestation length: results from a collaborative behavioral teratology study in Japan. Neurotoxicol Teratol 20:449–457.
Tachibana T, Terada Y, Fukunishi K, Tanimura T. 1996. Estimated magnitude of behavioral effects of phenytoin in rats and its reproducibility: a collaborative behavioral teratology study in Japan. Physiol Behav 60:941–952.
Tanimura T. 1985. Guidelines for developmental toxicity testing of chemicals in Japan. Neurobehav Toxicol Teratol 7:647–652.
Tanimura T. 1986. Collaborative studies on behavioral teratology in Japan. Neurotoxicology 7:35–45.
Tanimura T. 1992. Update on the Japanese Behavioral Teratology Meeting. Congenit Anom 32(suppl):S 7–S20.
Tilson HA, Jacobson JL, Rogan WJ. 1990. Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. Neurotoxicol Teratol 12:239–248.
Tilson HA, MacPhail RC, Moser VC, Becking GC, Cuomo V, Frantik E, et al. 1997. The IPCS Collaborative Study on Neurobehavioral Screening Methods: VII. Summary and conclusions. Neurotoxicology 18:1065–1069.
Tilson HA, Mitchell CL, Cabe PA. 1979. Screening for neurobehavioral toxicity: the need for and examples of validation of testing procedures. Neurobehav Toxicol(suppl 1):137–148.
Tilson HA, Wright DC. 1985. Interpretation of behavioral teratology data. Neurobehav Toxicol Teratol 7:667–668.
Tyl RW, Crofton KM, Moretto A, Moser V, Sheets LP, Sobotka TJ. 2008. Identification and interpretation of treatment-related effects in developmental neurotoxicity testing. Neurobehav Toxicol 30(4):349–381.
Tyl RW, Sette WF. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group III report: weight of evidence and quantitative evaluation of developmental neurotoxicity data. Neurotoxicol Teratol 12:275–280.
U.S. EPA (U.S. Environmental Protection Agency). 1986. Triethylene glycol monomethyl, monoethyl and monobutyl ethers: proposed test rule. Fed Reg 81(94):17883–17894.
U.S. EPA. 1991. Developmental Neurotoxicity Study, Series 83-6, Addendum 10 (Neurotoxicity), Subdivision F: Hazard Evaluation: Human and Domestic Animals. EPA 540/09-91-123. Washington, DC:U.S. Environmental Protection Agency.
U.S. EPA. 1995. Positive Control Requirement for Neurotoxicity Testing. Letter from American Industrial Health Commission (AIHC) to Richard Hill, U.S. EPA, Office of Prevention, Pesticides and Toxic Substances. Washington, DC:U.S. Environmental Protection Agency.
U.S. EPA (U.S. Environmental Protection Agency). 1998. Health Effects Guidelines OPPTS 870.6300 Developmental Neurotoxicity Study. EPA 712–C–98–239. Available: http://www.epa.gov/opptsfrs/publications/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Series/870-6300.pdf [accessed 8 December 2008].
U.S. EPA. 1999a. FIFRA Scientific Advisory Panel Meeting, December 8, 1998, held at the Sheraton Crystal Hotel, Arlington, VA, II—A Set of Scientific Issues Being Considered by the Environmental Protection Agency Regarding: A Retrospective Analysis of Developmental Neurotoxicity Studies, U.S. EPA, FIFRA SAP Report No. 99–01B, January 22, 1999. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/scipoly/sap/meetings/1998/december/final.htm [accessed 21 November 2008].
U.S. EPA (U.S. Environmental Protection Agency). 1999b. Neurotoxic pesticides; availability of data call-in notice. Fed Reg 64:42945–42947.
U.S. EPA. 2002a. Determination of the Appropriate FQPA Safety Factor(s) in Tolerance Assessment. Washington, DC:Office of Pesticide Programs, U.S. Environmental Protection Agency . Available: http://www.epa.gov/oppfead1/trac/science/determ.pdf [accessed 6 August 2008].
U.S. EPA. 2002b. A Review of the Reference Dose and Reference Concentration Processes. Washington, DC:U.S. Environmental Protection Agency Risk Assessment Forum.
U.S. EPA. 2006. Evaluation Report: Opportunities to Improve Data Quality and Children’s Health through the Food Quality Protection Act. Report No. 2006-P-00009. Washington, DC:Office of the Inspector General, U.S. Environmental Protection Agency.
Vorhees CV. 1985a. Behavioral effects of prenatal d-amphetamine in rats: a parallel trial to the Collaborative Behavioral Teratology Study. Neurobehav Toxicol Teratol 7:709–716.
Vorhees CV. 1985b. Behavioral effects of prenatal methylmercury in rats: a parallel trial to the Collaborative Behavioral Teratology Study. Neurobehav Toxicol Teratol 7:717–725.
Vorhees CV. 1985c. Comparison of the Collaborative Behavioral Teratology Study and Cincinnati Behavioral Teratology test batteries. Neurobehav Toxicol Teratol 7:625–633.
Vorhees CV. 1986. Methods for assessing the adverse effects of foods and other chemicals on animal behavior. Nutr Rev 44(suppl):185–193.
Vorhees CV, Butcher RE, Brunner RL, Sobotka TJ. 1979. A developmental test battery for neurobehavioral toxicity in rats: a preliminary analysis using monosodium glutamate calcium carrageenan, and hydroxyurea. Toxicol Appl Pharmacol 50:267–282.
Weiss B, Amler S, Amler RW. 2004. Pesticides. Pediatrics 113:1030–1036.
York RG, Barnett J Jr, Brown WR, Garman RH, Mattie DR, Dodd D. 2004. A rat neurodevelopmental evaluation of offspring, including evaluation of adult and neonatal thyroid, from mothers treated with ammonium perchlorate in drinking water. Int J Toxicol 23:191–214.
Zoetis T, Walls I. 2003. Principles and Practices for Direct Dosing of Pre-weaning Mammals in Toxicity Testing and Research. Washington, DC:ILSI Press.
Last Updated: December 12, 2008